SARS-CoV-2 Screening Test Kit

Whether contact with the SARS-CoV-2 (Corona 2019) virus has been present or not, our rapid test detects in only 20 minutes whether a patient is infected.

The detection of SARS-CoV-2 infection is based on the detection of SARS-CoV-2 specific IgM and IgG antibodies in capillary blood, whole blood or serum.


Increased levels of intact proinsulin in the blood are a highly specific indicator of a massive disorder of pancreatic insulin-producing cells (ß-cell dysfunction) and clinically relevant insulin resistance.

Non-alcoholic fatty liver is considered a hepatic manifestation of metabolic syndrome and NAFL is often associated with insulin resistance, which in turn promotes the progression of fatty liver disease.


The rapid diagnosis of metabolic diseases is an enormous opportunity for the patients and is one of the major medical tasks of today.

The life of patients can be decisively influenced and the outbreak of diseases can be prevented by early diagnosis. This is what our Lateralflow rapid tests stand for.

Our products are CE-compliant and are produced strictly according to the quality standard DIN ISO 13485:2016.


You can directly order our products via our shop system for medical professionals.

Our sales team will provide you with professional advice. Just write or call us. We would be happy to assist you.

Pharmact GmbH
International Distribution Headquarter
Telefon:   +49 (0) 621-1806178-0
Telefax:    +49 (0) 621-1806178-9

BELMONITOR CoV-2 - Detection of SARS-CoV-2

BelFIBRO® - Rapid hepatic status diagnosis (F0-F4)

BelCARDIO® - Did a Myocardial infarction?

BelDIA PRE® - Screening for Type 2 Diabetes